Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Buckingham

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
The Journal of Pharmacy and Pharmacology|March 1, 1975
Evidence for a central alpha-sympathomimetic action of clonidine in the ratL Finch, R E Buckingham, R A Moore, et al.
Journal of Cardiovascular Pharmacology|April 1, 1987
Alpha 1-adrenoceptor-mediated contraction of rabbit mesenteric artery: a role for intra- and extracellular calcium poolsC Wilson, S M Cooper, R E Buckingham, et al.
Diabetes|July 2, 1999
The thiazolidinedione rosiglitazone (BRL-49653) lowers blood pressure and protects against impairment of endothelial function in Zucker fatty ratsA B Walker, P D Chattington, R E Buckingham, et al.
Diabetes, Obesity & Metabolism|February 28, 2001
Rosiglitazone prevents the onset of hyperglycaemia and proteinuria in the Zucker diabetic fatty ratS A Smith, C A Lister, C D Toseland, et al.
The Journal of Pharmacy and Pharmacology|December 1, 1999
Differences between the vasorelaxant activity of adenosine-receptor agonists on guinea-pig isolated aorta precontracted with noradrenaline or phenylephrineW R Ford, H L Maddock, R E Buckingham, et al.
Obesity Research|August 10, 2000
Central exendin-4 infusion reduces body weight without altering plasma leptin in (fa/fa) Zucker ratsK A Al-Barazanji, J R Arch, R E Buckingham, et al.
Clinical Science (London, England : 1979)|October 24, 1997
Impaired insulin-induced attenuation of noradrenaline-mediated vasoconstriction in insulin-resistant obese Zucker ratsA B Walker, J Dores, R E Buckingham, et al.
British Journal of Pharmacology|May 1, 1989
Inhibition by glibenclamide of the vasorelaxant action of cromakalim in the ratR E Buckingham, T C Hamilton, D R Howlett, et al.
Regulatory Peptides|November 5, 1998
Characterisation of the neuropeptide Y receptor that mediates feeding in the rat: a role for the Y5 receptor?A C Haynes, J R Arch, S Wilson, et al.
Diabetes|May 20, 1998
Differential vasoactive effects of the insulin sensitizers rosiglitazone (BRL 49653) and troglitazone on human small arteries in vitroA B Walker, E K Naderali, P D Chattington, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
The Journal of Pharmacy and Pharmacology|March 1, 1975
Evidence for a central alpha-sympathomimetic action of clonidine in the ratL Finch, R E Buckingham, R A Moore, et al.
Journal of Cardiovascular Pharmacology|April 1, 1987
Alpha 1-adrenoceptor-mediated contraction of rabbit mesenteric artery: a role for intra- and extracellular calcium poolsC Wilson, S M Cooper, R E Buckingham, et al.
Diabetes|July 2, 1999
The thiazolidinedione rosiglitazone (BRL-49653) lowers blood pressure and protects against impairment of endothelial function in Zucker fatty ratsA B Walker, P D Chattington, R E Buckingham, et al.
Diabetes, Obesity & Metabolism|February 28, 2001
Rosiglitazone prevents the onset of hyperglycaemia and proteinuria in the Zucker diabetic fatty ratS A Smith, C A Lister, C D Toseland, et al.
The Journal of Pharmacy and Pharmacology|December 1, 1999
Differences between the vasorelaxant activity of adenosine-receptor agonists on guinea-pig isolated aorta precontracted with noradrenaline or phenylephrineW R Ford, H L Maddock, R E Buckingham, et al.
Obesity Research|August 10, 2000
Central exendin-4 infusion reduces body weight without altering plasma leptin in (fa/fa) Zucker ratsK A Al-Barazanji, J R Arch, R E Buckingham, et al.
Clinical Science (London, England : 1979)|October 24, 1997
Impaired insulin-induced attenuation of noradrenaline-mediated vasoconstriction in insulin-resistant obese Zucker ratsA B Walker, J Dores, R E Buckingham, et al.
British Journal of Pharmacology|May 1, 1989
Inhibition by glibenclamide of the vasorelaxant action of cromakalim in the ratR E Buckingham, T C Hamilton, D R Howlett, et al.
Regulatory Peptides|November 5, 1998
Characterisation of the neuropeptide Y receptor that mediates feeding in the rat: a role for the Y5 receptor?A C Haynes, J R Arch, S Wilson, et al.
Diabetes|May 20, 1998
Differential vasoactive effects of the insulin sensitizers rosiglitazone (BRL 49653) and troglitazone on human small arteries in vitroA B Walker, E K Naderali, P D Chattington, et al.
Pageof 4